These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 8064160

  • 1. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y, Suzuki Y, Suzuki E, Hayakawa H, Kimura K, Goto A, Omata M, Minamino N, Kangawa K, Matsuo H.
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats.
    Hirata Y, Suzuki E, Hayakawa H, Matsuoka H, Sugimoto T, Kangawa K, Matsuo H.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):283-90. PubMed ID: 7511759
    [Abstract] [Full Text] [Related]

  • 3. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I, Gonzalez W, el Amrani AI, Fournié-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [Abstract] [Full Text] [Related]

  • 4. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
    Itoh H, Nakao K, Mukoyama M, Yamada T, Hosoda K, Shirakami G, Morii N, Sugawara A, Saito Y, Shiono S.
    J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
    [Abstract] [Full Text] [Related]

  • 5. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W, Fournié-Zaluski MC, Pham I, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [Abstract] [Full Text] [Related]

  • 6. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I, el Amrani AI, Fournié-Zaluski MC, Corvol P, Roques B, Michel JB.
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [Abstract] [Full Text] [Related]

  • 7. Effects of a neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats.
    Nakajima S, Majima M, Ito H, Hayashi I, Yajima Y, Katori M.
    Int J Tissue React; 1998 Dec; 20(2):45-56. PubMed ID: 9638501
    [Abstract] [Full Text] [Related]

  • 8. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y, Matsuoka H, Suzuki E, Hayakawa H, Sugimoto T, Matsuda Y, Morishita Y, Kangawa K, Minamino N, Matsuo H.
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [Abstract] [Full Text] [Related]

  • 9. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T, Okahara A, Nose M, Ikuse T, Matsumura Y.
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M, Hirth-Dietrich C, Stasch JP.
    Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
    [Abstract] [Full Text] [Related]

  • 13. Chronic endopeptidase inhibition in DOCA-salt hypertension: mechanism of cardiovascular protection.
    Newaz MA, Yousefipour Z, Hercule H, Truong L, Oyekan A.
    Clin Exp Hypertens; 2003 Aug; 25(6):335-47. PubMed ID: 12940471
    [Abstract] [Full Text] [Related]

  • 14. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M, Ganten D, Stasch JP.
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [Abstract] [Full Text] [Related]

  • 15. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
    Seymour AA, Norman JA, Asaad MM, Fennell SA, Abboa-Offei B, Little DK, Kratunis VJ, Delaney NG, Hunt JT, Di Donato G.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1002-9. PubMed ID: 1826031
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
    Trapani AJ, Beil ME, Coté DT, de Lombaert S, Erion MD, Gerlock TE, Ghai RD, Hopkins MF, Peppard JV, Webb RL.
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):358-64. PubMed ID: 7515977
    [Abstract] [Full Text] [Related]

  • 17. Characterization of atrial natriuretic peptide in urine from rats treated with a neutral endopeptidase inhibitor.
    Suzuki E, Hirata Y, Matsuoka H, Sugimoto T, Hayakawa H, Sugimoto T, Kangawa K, Minamino N, Matsuo H.
    Biochem Biophys Res Commun; 1992 Feb 14; 182(3):1270-6. PubMed ID: 1531753
    [Abstract] [Full Text] [Related]

  • 18. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF, Jin HK, Paul R, Nagahama S.
    J Pharmacol Exp Ther; 1988 Aug 14; 246(2):485-92. PubMed ID: 2969976
    [Abstract] [Full Text] [Related]

  • 19. Preventive effects of low molecular mass potassium alginate extracted from brown algae on DOCA salt-induced hypertension in rats.
    Chen YY, Ji W, Du JR, Yu DK, He Y, Yu CX, Li DS, Zhao CY, Qiao KY.
    Biomed Pharmacother; 2010 Apr 14; 64(4):291-5. PubMed ID: 19932586
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
    Seymour AA, Asaad MM, Abboa-Offei BE, Rovnyak PL, Fennell S, Rogers WL.
    J Pharmacol Exp Ther; 1992 Jul 14; 262(1):60-70. PubMed ID: 1385630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.